NYLIM
INSP icon

New York Life Investment Management’s Inspire Medical Systems INSP Stock Holding History

New York Life Investment Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,560
Closed -$476K – 859
2024
Q2 		$476K Buy
3,560
+387
+12% +$73.2K ﹤0.01% 806
2024
Q1 		$682K Sell
3,173
-99
-3% -$19.4K 0.01% 757
2023
Q4 		$666K Buy
+3,272
New +$530K 0.01% 747
2023
Q3 		– Sell
-1,435
Closed -$466K – 1304
2023
Q2 		$466K Buy
+1,435
New +$410K ﹤0.01% 777

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New York Life Investment Management's INSP Position: Q3 2024 in Review

New York Life Investment Management sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 3,560 shares — an estimated $476K sold.

New York Life Investment Management first reported a position in INSP in Q2 2023 and held it in 4 quarters. The position peaked at $682K in Q1 2024. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • New York Life Investment Management reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
  • New York Life Investment Management sold 3,560 Inspire Medical Systems shares in Q3 2024, an estimated $476K.
  • New York Life Investment Management first reported a position in Inspire Medical Systems in Q2 2023 and held it in 4 quarters.
  • New York Life Investment Management's Inspire Medical Systems position peaked at $682K in Q1 2024.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on New York Life Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.